DZHK Conference 2019

Day 2

Thursday, 10 January 2019

3rd Session: Translators

Chairs: Holger Gerhardt (Berlin) | Stephan Felix (Greifswald)

08:30 - 09:00 Bert Klebl, Dortmund LDC – A (proven) model for bridging academia to “pharmaceutical industry”
09:00 - 09:30 Jérôme Van Biervliet, Ghent Basic science, translational medicine and how to translate to value: The VIB experience
09:30 - 10:00 Timothy McKinsey, Aurora Early Translation in Academia: Drugging the Unthinkable for Heart Failure
10:00 - 10:30 Coffee break

4th Session: Translational Projects | DZHK

Chairs: Alexandra Lansky (New Haven) | Garret A. FitzGerald (Philadelphia)

10:30 - 10:45 Stefan Luther, Göttingen Low energy defibrillation
10:45 - 11:00 Florian Weinberger, Hamburg Engineered heart tissue transplantation for cardiac repair – towards first-in-patient
11:00 - 11:15 Esther Lutgens, Munich CD40-TRAF6 inhibitors in Cardiovascular disease
11:15 - 11:30 Patrick Most, Heidelberg Peptide-based therapy development for cardiac failure treatment
11:30 - 11:45 Lucie Carrier, Hamburg Gene therapy for myofilament disorders
11:45 - 12:00 Wolfram-Hubertus Zimmermann, Göttingen GMP-Production of engineered human myocardium for heart failure repair

 

12:00 - 13:00: Lunch break
13:00 - 14:00: 2nd parallel poster session (No. 16-25 / No. 26-35)


5th Session: Biotech

Chairs: Ingrid Fleming (Frankfurt am Main) | Thorsten Kessler (Munich)

14:00 - 14:30 Martin Ungerer, Munich Development of biologicals
14:30 - 15:00 Craig January, Madison The CDI Story
15:00 - 15:30 Kenneth Walsh, Virginia Killer Clones: Clonal Hematopoiesis and Age-associated Disease
Concluding remarks Gerd Hasenfuß, Göttingen
Coffee & Goodbye

The talk by John T. Gray was regretfully cancelled.


6th Session: Path to discovery

The talk by Graziella Pellegrini was regretfully cancelled. Kenneth Walsh will give his talk in the 5th session.